Sileo is a drug owned by ORION CORP. It is protected by 1 US drug patent filed in 2033. All patents are active. Details of Sileo’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US10780079 | Active | |
Exclusivity Information
Sileo holds 1 exclusivity out of which 1 has expired. Details of Sileo's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Nov 19, 2018 |
About Sileo
Sileo is a drug
owned by ORION CORP.
Sileo uses
Dexmedetomidine as the active
ingredient.
Active Ingredient:
Sileo uses
Dexmedetomidine as the active ingredient.
Check out other Drugs and Companies using
Dexmedetomidine ingredient.